We confirmed the synergistic effect of PRMT5 inhibition and MSI2 knockdown on cell proliferation by performing the immunohistochemical analysis of Ki-67, a biomarker of proliferating cancer cells25 (Fig. 3I). Here, MKI67 is linked to cancer.